Literature DB >> 16002633

Immunoglobulin G subclass profile of antimeasles response in vaccinated children and in adults with measles history.

Anna P Toptygina1, Alexander L Pukhalsky, Vladimir A Alioshkin.   

Abstract

The aim of this study was to investigate measles-specific immunoglobulin G (IgG) subclass profile in vaccinated children and in adults with natural infection. Serum samples were collected before and 30 days after vaccination. The sera from 51 late convalescent adults and seven adults with natural measles infection at the 12th day after onset of rash have been also investigated. Measles IgG antibodies and specific IgG subclasses were tested by enzyme-linked immunosorbent techniques. In children younger than 3 years, the predominant subclass was IgG3, which contributed, on average, 63.3% of the total IgG response. The contributions of specific IgG1 and IgG4 to the total IgG antimeasles response were lower (19.9% and 16.8%, respectively), whereas IgG2 was not found. In contrast, in the group of children older than 4 years, just IgG2 was a predominant subclass; it contributed 42.6% of the total IgG response. Other subclasses were also present but the contribution was much lower. In adult volunteers with measles history, IgG2 was a predominant subclass of total IgG. Thus, in early convalescence IgG2 contributed 62% of the total IgG response, whereas in late convalescence the contribution was lower (41.4%). There were no visible differences in IgG subclass composition between subjects with natural infection and vaccinated children except those below 3 years of age. The humoral immune response of such subjects is immature and the IgG2 subclass of virus-specific antibodies has not been revealed in the sera.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002633      PMCID: PMC1182202          DOI: 10.1128/CDLI.12.7.845-847.2005

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  16 in total

1.  The IgG subclass profile of anti-HBs response in vaccinated children and children seroconverted after natural infection.

Authors:  H Gregorek; K Madaliński; M Woynarowski; J Mikołajewicz; M Syczewska; J Socha
Journal:  Vaccine       Date:  2000-01-18       Impact factor: 3.641

Review 2.  Principles of measles control.

Authors:  F T Cutts; R H Henderson; C J Clements; R T Chen; P A Patriarca
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

3.  IgG subclass levels in infancy and childhood.

Authors:  V A Oxelius
Journal:  Acta Paediatr Scand       Date:  1979-01

4.  Immunoglobulin G subclass restriction of antibodies against hepatitis B surface antigen.

Authors:  A Morell; B Roth-Wicky; F Skvaril
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

5.  IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines.

Authors:  T Parkkali; H Käyhty; M Anttila; T Ruutu; T Wuorimaa; A Soininen; L Volin; P Ruutu
Journal:  Bone Marrow Transplant       Date:  1999-09       Impact factor: 5.483

6.  Comparison of immunoglobulin G subclass profiles induced by measles virus in vaccinated and naturally infected individuals.

Authors:  María Beatríz Isa; Laura Martínez; Miguel Giordano; Carlos Passeggi; María Cristina de Wolff; Silvia Nates
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

7.  Measles virus-specific immunoglobulin G isotype immune response in early and late infections.

Authors:  M B Isa; L Martínez; M Giordano; M Zapata; C Passeggi; M C De Wolff; S Nates
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

8.  The serum IgG subclass levels in healthy infants of 13--62 weeks of age.

Authors:  B J Zegers; M van der Giessen; E E Reerink-Brongers; J W Stoop
Journal:  Clin Chim Acta       Date:  1980-02-28       Impact factor: 3.786

9.  Measles virus protein-specific IgM, IgA, and IgG subclass responses during the acute and convalescent phase of infection.

Authors:  H S El Mubarak; S A Ibrahim; H W Vos; M M Mukhtar; O A Mustafa; T F Wild; A D M E Osterhaus; R L de Swart
Journal:  J Med Virol       Date:  2004-02       Impact factor: 2.327

10.  IgG subclass composition of antibodies to HBsAg in circulating immune complexes from patients with hepatitis B virus infections.

Authors:  S Rath; M E Devey
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

View more
  6 in total

1.  The human thymus perivascular space is a functional niche for viral-specific plasma cells.

Authors:  Sarah Nuñez; Carolina Moore; Baoshan Gao; Kortney Rogers; Yessia Hidalgo; Pedro J Del Nido; Susan Restaino; Yoshifumi Naka; Govind Bhagat; Joren C Madsen; María Rosa Bono; Emmanuel Zorn
Journal:  Sci Immunol       Date:  2016-12-23

2.  Immunogenicity after outbreak response immunization activities among young healthcare workers with secondary vaccine failure during the measles epidemic in Korea, 2019.

Authors:  Hyeri Seok; Erica Españo; Jooyun Kim; Ji Hoon Jeon; Won Suk Choi; Yun-Kyung Kim; Jeong-Ki Kim; Dae Won Park
Journal:  BMC Infect Dis       Date:  2022-06-08       Impact factor: 3.667

3.  Autism: maternally derived antibodies specific for fetal brain proteins.

Authors:  Daniel Braunschweig; Paul Ashwood; Paula Krakowiak; Irva Hertz-Picciotto; Robin Hansen; Lisa A Croen; Isaac N Pessah; Judy Van de Water
Journal:  Neurotoxicology       Date:  2007-11-06       Impact factor: 4.294

4.  Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study.

Authors:  Lisa A Croen; Daniel Braunschweig; Lori Haapanen; Cathleen K Yoshida; Bruce Fireman; Judith K Grether; Martin Kharrazi; Robin L Hansen; Paul Ashwood; Judy Van de Water
Journal:  Biol Psychiatry       Date:  2008-06-20       Impact factor: 13.382

Review 5.  HIV-1-specific antibody responses during acute and chronic HIV-1 infection.

Authors:  Georgia D Tomaras; Barton F Haynes
Journal:  Curr Opin HIV AIDS       Date:  2009-09       Impact factor: 4.283

6.  Adeno-associated virus serotype 2 induces cell-mediated immune responses directed against multiple epitopes of the capsid protein VP1.

Authors:  Declan Madsen; Emma R Cantwell; Timothy O'Brien; Patricia A Johnson; Bernard P Mahon
Journal:  J Gen Virol       Date:  2009-07-29       Impact factor: 3.891

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.